Class II
Terminated
CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Col…
Why: CGMP Deviations
- Company
- Edge Pharma, LLC
Colchester, VT, United States - Reported
- Feb 2, 2022
- Recall started
- Dec 6, 2021
- Ended
- Jun 7, 2023
- Where sold
- nationwide
- Amount
- 1055 bottles
- Full product description
- CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1633-05
- Lots / codes affected
- 10-2021-27@8 01-25-2022
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.